Immutopics Didn't Infringe Antibody Patent: Fed. Circ.
A federal appeals court has upheld Immutopics Inc.'s summary judgment of noninfringement victory in a Scantibodies Laboratory Inc. suit accusing the bone health assay manufacturer of infringing a patent for methods...To view the full article, register now.
Already a subscriber? Click here to view full article